Document Detail

Angiogenic growth factors: potential new treatment for acute myocardial infarction?
MedLine Citation:
PMID:  10728349     Owner:  NLM     Status:  MEDLINE    
In models of hind-limb ischemia and progressive coronary artery occlusion, angiogenic growth factor proteins and genes expressing growth factors have been shown to induce the development of collateral vessels and remodeling of existing collaterals. The therapeutic potential of growth factors in the setting of acute myocardial infarction may be related to non-angiogenic properties of growth factors as well, and is the focus of this review.
L M Gonçalves
Related Documents :
12135129 - Shunt between the ventricular chamber and coronary arteries preserves left ventricular ...
21752089 - Unusual left atrial mass: inverted left atrial appendage caused by massive pericardial ...
17418299 - Endothelial nitric oxide synthase overexpression provides a functionally relevant angio...
7873419 - Myocardial oxygen supply-demand relations during isovolemic hemodilution.
10728349 - Angiogenic growth factors: potential new treatment for acute myocardial infarction?
15181129 - Influence of angiographic collateral circulation on myocardial perfusion in patients wi...
8911849 - Multiple recurrence of a "sporadic" (non-familial) cardiac myxoma.
8154429 - Echocardiographic findings in 104 professional cyclists with follow-up study.
18053159 - Native cardiac reserve predicts survival in acute post infarction heart failure in mice.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiovascular research     Volume:  45     ISSN:  0008-6363     ISO Abbreviation:  Cardiovasc. Res.     Publication Date:  2000 Jan 
Date Detail:
Created Date:  2000-04-11     Completed Date:  2000-04-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0077427     Medline TA:  Cardiovasc Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  294-302     Citation Subset:  IM    
Cardiology Department, Coimbra University Hospital, Portugal.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Collateral Circulation
Fibroblast Growth Factors / therapeutic use
Growth Substances / therapeutic use*
Myocardial Infarction / drug therapy*,  physiopathology
Somatomedins / therapeutic use
Reg. No./Substance:
0/Growth Substances; 0/Somatomedins; 62031-54-3/Fibroblast Growth Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cardiac fatty acid uptake and transport in health and disease.
Next Document:  Effect of physiological mechanical perturbations on intact human myocardial repolarization.